CrossrefInfokarte
Dose reduction of ibrutinib in chronic lymphocytic leukemia: long-term outcomes from a real-world single-center experience
Mediterranean Journal of Hematology and Infectious Diseases · 2026-10-31 · 18 (1) · e2026090
DOI: 10.4084/mjhid.2026.090 ↗Abstract
A real-world experience on dose reduction of ibrutinib in chronic lymphocytic leukemia is reported.
EUVIMED